Bain Capital Life Sciences Investors, LLC Century Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $298 Million
- Q1 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 5,410,361 shares of IPSC stock, worth $2.81 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
5,410,361
Previous 5,410,361
-0.0%
Holding current value
$2.81 Million
Previous $5.46 Million
52.49%
% of portfolio
0.87%
Previous 1.48%
Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
66Shares Held
26.1MCall Options Held
12.1KPut Options Held
0-
Casdin Capital, LLC New York, NY3.21MShares$1.67 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.51 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.3 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$1.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.02MShares$1.05 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $30.6M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...